TotalMarketCap

Aquestive Therapeutics

AQSTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$458.132 M

$3.65 -4.08%

Close of 6 Nov 2026

As of 6 Nov 2026, Aquestive Therapeutics (AQST) has a market capitalization of $458.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$44.5M

#2752 by revenue

Earnings

-$83.8M

Loss-making

Shares outstanding

125,687,705

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #192Crescent BiopharmaCBIO$482.1M
  2. #193CytomX TherapeuticsCTMX$467.4M
  3. #194Aquestive TherapeuticsAQST$458.1M
  4. #195EvolusEOLS$452.4M
  5. #196Monopar TherapeuticsMNPR$450.8M

What if Aquestive Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$224,659.00

Per share 61,635× higher

Bitcoin $1.53T

$12,155.91

Per share 3,335× higher

Apple $5.02T

$39,906.71

Per share 10,948× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Aquestive Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.